Editorial · 2015
Conference abstractPublished 14 Sep 2015
The wrong prescription of dialysis fluid
Via Medis Dialysis Center, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The worldwide use of acidification with 3 mmol/L of acetate is critical, as there is a big problem of calcification. The majority of the CKD-5 patients has own big problems with calcification. After each Dialysis it is necessary to descale the monitor. Only the patient never will be descaled. To elevate the dosage of acetate is no good idea as the production of CO2 becomes bigger. This is a problem for cold patients as well as for patients weaning from the respirator. The alternative prescription with 1 mmol/L citrate has the same amount of CO2 production as 3 mmol/L acetate but the dialysis fluid with citrate never has a problem of calcification. There is a second principle of working, the chelate binding of the two problems ions Ca++ and Mg++. Unfortunately, this essential problem will not well understand by the doctors and by the FDA Department, medical products as it is a problem of chemical solubility. Dialysis concentrate is a medical product and so there is no follow-up concerning this calcification problem. First target is to reach a chemical evaluation; second target is the prohibition of dialysis concentrate by 3 mmol/L acetate.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 31 Jan 2025
Recent Advances in Peritoneal Dialysis: A Narrative Review of Developments in Dialysis Fluid
Perspective · 11 Jul 2023
Child-friendly Peritoneal Dialysis Fluids: Enhancing Comfort and Efficiency in Pediatric Care
Perspective · 30 Jun 2022
Chronic kidney failure: Dialysis (The procedure for eliminating waste and extra fluid from the body)
Conference abstract · 2020
Does Ultrapure Dialysis Fluid Improve Quality of Life in Hemodialysis Patients?
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Thomas Ryzlewicz”

